IL-2 B-DNA
gene I-DNA
expression O
and O
NF-kappa B-protein
B I-protein
activation O
through O
CD28 B-protein
requires O
reactive O
oxygen O
production O
by O
5-lipoxygenase B-protein
. O

This O
differential O
effect O
of O
E1A B-protein
expression O
on O
the O
cytolytic O
phenotypes O
of O
infected O
and O
stably O
transfected O
human B-cell_type
cells I-cell_type
suggests O
that O
human B-cell_type
NK I-cell_type
cells I-cell_type
provide O
an O
effective O
immunologic O
barrier O
against O
the O
in O
vivo O
survival O
and O
neoplastic O
progression O
of O
E1A-immortalized B-cell_line
cells I-cell_line
that O
may O
emerge O
from O
the O
reservoir O
of O
persistently B-cell_type
infected I-cell_type
cells I-cell_type
in O
the O
human O
host O
. O

In O
addition O
, O
when O
used O
together O
IL-2 B-protein
and O
IL-12 B-protein
synergized O
in O
the O
induction O
of O
IFN-gamma B-protein
and O
GM-CSF B-protein
and O
this O
synergy O
was O
attributed O
to O
an O
increased O
accumulation O
and O
stability O
of O
the O
IFN-gamma B-RNA
and I-RNA
GM-CSF I-RNA
mRNAs I-RNA
. O

In O
contrast O
, O
IL-12 B-protein
induction O
of O
IFN-gamma B-RNA
cytoplasmic I-RNA
mRNA I-RNA
appears O
to O
only O
partially O
depend O
on O
activation O
of O
protein B-protein
kinase I-protein
C I-protein
. O

Northern O
blot O
analysis O
indicated O
the O
expression O
of O
human O
PEBP2 B-protein
alpha I-protein
A I-protein
, O
alpha B-DNA
B I-DNA
( O
AML1 B-DNA
) O
, O
and O
beta B-DNA
genes I-DNA
in O
Jurkat B-cell_line
cells I-cell_line
. O